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Rutin and quercetin, both minor components of green tea and their Cu(II) complexes interact with
Ribonuclease A (RNase A) in a novel way. The effects of rutin, quercetin and their copper complexes
on the catalytic activity of the protein were investigated. Rutin shows an enhancement in the ribo-
nucleolytic activity whereas the copper complexes and quercetin behave as non-competitive type
inhibitors with Ki values in the lM range. The secondary structural changes of RNase A in presence
of the ligands were measured by circular dichroism and Fourier transform infrared spectroscopy.
The binding parameters were obtained using a ﬂuorescence quenching analysis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction RNase A [7]. The inhibition of angiogenin has shown suppressionThere exists a crucial balance between RNA polymerases that
synthesize RNA and RNA depolymerases, also known as ribonucle-
ases (RNase) that degrade RNA [1]. The central thesis of DNA to
RNA to protein is largely dependent on the action of these proteins.
RNases can be cytotoxic at higher levels by entering the cytosol
and retaining their ribonucleolytic activity and degrading cellular
RNA, and in turn inhibiting protein synthesis that subsequently
causes cell death [2]. Studies have shown that several pancreatic
RNase A homologues, including angiogenin, eosinophil-derived
neurotoxin, and bovine seminal RNase A, utilize their enzymatic
activities to bring forth potent physiological effects [3–5]. This
has led to widespread interest and increase in the development
of synthetic or natural ribonuclease inhibitors [4]. Out of the four
His residues in the protein His 12, 48, 105 and 119, His 12 and
His 119 are present in the P1 subsite of the active site of the
enzyme and are mainly engaged in the phosphodiester hydrolysis
mechanism [6]. Of the homologues known, angiogenin, a potent
blood vessel inducer, has a structural similarity of 60% withchemical Societies. Published by E
uercetin; Rut, Rutin; QuCu,
ex; 20 ,30-cCMP, cytidine 20 ,30
cid; CD, circular dichroism;
lear magnetic resonance
ata_dasgupta@hotmail.comof growth and metastasis of solid tumors [4,8,9]. It has been dem-
onstrated that ribonuclease activity increased in cancer cells, and
in the serum and urine of the affected to a level much higher than
the control. This was observed in humans as well as animals. Inter-
estingly the activity of the ribonuclease inhibitor was found to
decrease in cancer tissues [9]. Thus, the development of inhibitors
has become essential.
A recent investigation has shown that natural polyphenols from
red wine and green tea [10] prevent angiogenesis (new blood ves-
sel formation) [11]. Rutin is the glycoside between the ﬂavonol
quercetin and the disaccharide rutinose. The two components rutin
and the aglycone rutin (quercetin) (Fig. 1) are present in fruits, red
wine, tea (black, green), grape, orange, wheat, onion and soybean.
Both quercetin and rutin are known to exhibit antioxidant [11],
anti-inﬂammatory [12] and anticancer [13] activities.
In the human diet a trace amount of copper is present which acts
as a cofactor for angiogenesis [14]. Speciﬁc drugs are oftentimes
used to decrease the concentration level of copper in blood via
chelation. Penicillamine [15], captopril [16] and ammonium tetra-
thiomolybdate [17] are known chelators of copper that have been
used for antiangiogenic therapy, though side effects have also been
observed [18]. Thus, copper complexation by naturally occurring
compounds from dietary constituents that have antiangiogenic
activity can be exploited as potentially better antiangiogenic
compounds [19].
We have investigated the effect of quercetin and rutin and their
Cu(II) complexes [20] on the ribonucleolytic activity of RNase A. Aslsevier B.V. All rights reserved.
Fig. 1. The chemical structures of rutin and quercetin.
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enzymes [21,22], agarose gel followed by a precipitation assay
and kinetic experiments were performed. 1H NMR experiments
were performed to understand the mode of binding with the
compounds. Secondary structural changes due to complexation
were also studied by CD and FTIR spectroscopy. To determine the
binding constant of the compounds with RNase A and number of
binding sites per protein, ﬂuorescence quenching studies were
performed.
2. Materials and methods
2.1. Materials
RNase A, yeast (t-RNA), cytidine 20,30-cyclic monophosphate
(20,30-cCMP), quercetin and rutin were from Sigma–Aldrich (USA)
and other reagents from SRL India. A Perkin–Elmer UV–vis spectro-
photometer (Lambda 25) and a Horiba Jobin Yvon Spectroﬂuorom-
eter (Fluoromax-4) were used for the spectral measurements.
Concentrations were determined using the following data: RNase
A e278.5 = 9800 M1 cm1 [23]; 20,30-cCMP e268 = 8500 M1 cm1
[24] in water.
2.2. Determination of metal polyphenol stoichometry
The preparation and characterization procedure including the
geometry optimized structure of the complexes are included in
the Supplementary data.
2.3. Agarose gel-based assay
RNase A (2 lM, 20 ll) was mixed with 10 ll of Tris-acetic acid
buffer (pH 8) and 20 ll (200 lM) each rutin, quercetin and their
copper complexes incubated for 5 h. Aliquots (20 ll) were incu-
bated with 20 ll of t-RNA (16.6 mg/ml, freshly dissolved in RNase
A free buffer) and incubated for 15 min. Sample buffer (10 ll) with
10% glycerol and 0.025% bromophenol blue was added to quench
the reaction. Aliquots (15 ll) were loaded onto a 1.1% agarose gel
and the undegraded t-RNA visualized by ethidium bromide
staining.
2.4. Precipitation assay
The ribonucleolytic activity of RNase A was assayed by the pre-
cipitation method as described by Bond et al. [25]. RNase A (4 lM,
10 ll) was mixed with 90 ll of each ligand (0–280 lM) and incu-
bated for 4 h. The solution was treated with 50 ll of t-RNA
(20 mg/ml) and 50 ll of HSA (0.5 mg/ml) in 5 mM Tris–HCl buffer
pH 7.5 for 30 min. Ice cold 1.14 N perchloric acid (200 ll)containing 6 mM uranyl acetate was added to quench the reaction.
The solution was chilled at 0 C for 30 min and centrifuged at 4 C
at 12000 rpm for 5 min. The supernatant (50 ll) was diluted to
1000 ll and the change in absorbance measured at 260 nm with
respect to a control set.
2.5. Inhibition kinetics
The effect of the polyphenols and their copper complexes on the
ribonucleolytic activity of RNase A was checked following the
method described by Anderson et al. [24].The assay was carried
out in oligo vinylsulfonic acid free 0.1 M Mes-NaOH buffer, pH
6.0 containing 0.1 M NaCl and 20,30-cCMP as the substrate [26].
The substrate concentration was varied from 0.2 to 0.9 mM and
the inhibitor concentration from 0 to 30 lM. The inhibition con-
stant and the type of binding enzyme were established from
Lineweaver–Burk plots.
2.6. Fluorescence spectroscopy
The emission spectra were recorded from 290 to 400 nm with
excitation at 275 nm [27] with a 5 nm slit width. A quantitative
analysis of the interaction of ligands [28] with RNase A was
performed by titration in 20 mM phosphate buffer of pH 7. A 3 ml
solution of RNase A was titrated with successive addition of the
respective ligands (0–15 lM). Interaction studies of the ligands
were performedwith amaximum alcohol content of 4% for all stud-
ies, which does not cause any structural change to the protein [29].
2.7. Circular dichroism measurements
CD measurements were carried out on a Jasco-810 automatic
recording spectrophotometer, using a 1 mm path length quartz
cell. The spectra were recorded in the range of 190–240 nm with
a scan rate of 50 nm/min and a response time of 4 s. Three scans
were accumulated for each spectrum. Results were expressed as
ellipticity and secondary structure determined using DICHROWEB,
an online server [30].
2.8. Fourier Transform infrared (FT-IR) studies
RNase A (200 lM) was dissolved in 20 mM phosphate buffer of
pH 7.0. RNase A:ligand ratios of 1:0.5 and 1:1 were prepared for
these ligands. FT-IR measurements were carried out at room
temperature on a Nexus-870 FT-IR spectrometer (Thermo Nicolet
Corporation) equipped with a Zn/Se-attenuated total reﬂection
(ATR) accessory, a DTGS KBr detector and a KBr beam splitter.
Secondary structure information was determined following the
method of Byler and Susi [31].
2.9. Melting point determination
A ﬂuorescence based approach [32] was used to measure the Tm
of RNase A in the presence and absence of the ligand. The ﬂuores-
cence intensity of Tyr was measured at various temperatures.
RNase A (4 lM) was mixed with 4 lM of each ligand and heated
from 40 to 75 C in 5 C increments and the ﬂuorescence intensity
measured following excitation at 275 nm and emission monitored
at 308 nm. The change in ﬂuorescence intensity (DF value) was
plotted with respect to temperature and the Tm value determined
from the derivative curve.
2.10. NMR of proteins
Exchangeable hydrogen atoms of RNase A were replaced with
deuterium by dissolving the protein in D2O with incubation for
Fig. 3. Relative ribonucleolytic activity plots of RNase A by Rut (), Qu (N), RutCu
(j), QuCu (d).
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Quirk and Raines [33,34]. This procedure was performed thrice.
The lyophilized protein was dissolved in D2O. The [ligand] to
[enzyme] molar ratio was maintained at 5:1 for all the compounds.
1H NMR spectra were recorded on a Bruker 400 MHz spectrometer
at 22.5 C. The ligand was dissolved in CD3CN (0.1 ml) and
deutorated RNase A was dissolved in (0.6 ml D2O). The acquisition
time was 2 s with 100 scans. The d value was recorded with respect
to 3-trimethylsilylpropane sulfonic acid (DSS).
3. Results and discussion
In vivo, green tea and grape juice have the ability to inhibit the
angiogenesis process. The effect of these compounds combined
with promising results for copper reduction therapy provide a plat-
form for the development of complexes with therapeutic potential.
Previous studies prompted us to investigate the effect of quercetin
and rutin (Fig. 1) and their copper complexes on the enzymatic
activity of RNase A. This can be extended to study the enzymatic
activity against speciﬁc proteins of the Ribonuclease superfamily
that demonstrate unusual biological activity, such as angiogenin.
The effect of the polyphenols and their copper complexes on
RNase A was assayed qualitatively by the degradation of t-RNA
in an agarose gel based assay. The extent of degradation of t-RNA
was estimated by observing the intensity of stained ethidium bro-
mide as shown in Fig. 2. The ability of the ligand to affect enzyme
activity is measured in terms of the extent of t-RNA degradation
from the differential intensity observed. The most intense band
observed in lane 6 corresponds to that of undegraded t-RNA. The
intensity for the degradation of t-RNA by RNase A is shown in lane
5 and considered as the control since it is indicative of the
maximum degradation possible by the protein alone. Results from
the polyphenols and their complexes distinctly show that in lane 1
the intensity of the band is less intense with respect to lane 5. This
indicates that in case of rutin the activity of RNase A is enhanced.
This has been conﬁrmed by the precipitation assay and enzyme ki-
netic studies. In case of Qu, RutCu and QuCu, the bands indicate
varying degrees of inhibition of the enzyme by the ligands. A quan-
titative estimation of the relative inhibitory power of the polyphe-
nols and their copper complexes on RNase A was estimated from
the precipitation assay. The results obtained from this study also
indicate activation of RNase A by rutin with quercetin and the cop-
per complexes exhibiting inhibitory activity. The order of inhibi-
tion of RNase A by the compounds is RutCu < Qu < QuCu with
IC50 values of 245 lM, 236 lM and 204 lM respectively (Fig. 3).
Speciﬁc constants obtained from kinetic experiments conﬁrmed
the nature of inhibition as shown in the panels of Fig. 4. RutinFig. 2. (a) Agarose gel-based assay for the inhibition of RNase A by rutin, quercetin ashowed activation with a Ki value of ()28 ± 5 lM with quercetin
exhibiting mixed type inhibition characteristics with a Ki value
74 ± 1 lM. The corresponding copper complexes of rutin and quer-
cetin showed non-competitive inhibition with Ki values of 122 ± 2
and 14 ± 5 lM respectively. The scheme for the modes of inhibition
is given in the following diagram:
where E is the enzyme, S the substrate, I the inhibitor and P the
product; here Ks = [E][S]/[ES], aKs = [EI][S]/[ESI]; Ki = [E][I]/[EI],
aKi = [ES][I]/[ESI]; kp = rate constant for the breakdown of ES to P;
b kp = rate constant for the breakdown of ESI to P. The simplest
mixed system is one in which EI has a lower afﬁnity than E for S,
and the ESI complex is non-productive. This means a > 1 andnd their copper complexes and (b) the corresponding histogram band intensity.
Fig. 4. Lineweaver–Burk plots for inhibition of RNase A by (a) Rutin, (b) Qu, (c) RutCu, and (d) QuCu. Concentrations of ligands are 30 lM (), 15 lM (j), 0 lM (N) for Rutin
and 14 lM (), 7 lM (j), 0 lM (N) for other compounds.
Table 1
The inhibition constant values and mode of inhibition for the rutin, quercetin and
their copper complexes against ribonucleolytic activity of RNase A.
Inhibitor a b Ki (lM) Mode of inhibition
Rut 0.92 0.99 ()28 ± 5 Hyperbolic mixed-type
Qu 2.98 0 74 ± 1 Linear mixed-type
RutCu 1 0 122 ± 2 Non-competitive
QuCu 1 0 14 ± 5 Non-competitive
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tive inhibition and pure non-competitive inhibition. This system is
referred to as a linear mixed-type inhibition. Another possibility
arises when the inhibitor decreases the rate constant for product
formation, but at the same time the afﬁnity of the enzyme for the
substrate. This can be described as a < 1, b < 1, and also b > a. In
other words kp has decreased, but Ks has decreased much more.
There may be some doubt whether I in this case should be referred
to as an inhibitor or an activator. This type of character is exhibited
in a type of hyperbolic mixed type of inhibition [35]. The corre-
sponding a, b, Ki values are tabulated in Table 1.
The CD spectra of RNase A in the presence and absence of
increasing amounts of polyphenols and their copper complexes
show signiﬁcant changes at 208 and 215–222 nm indicating con-
formational changes of secondary structure of RNase A (Fig. 5).
For CD studies the concentration of RNase A was 15 lM. Two sets
of RNase A-ligand complexes were prepared maintaining an RNase
A to ligand ratio of 1:0.5 and 1:1 respectively. Interestingly, the
data for rutin RNase A displays a decreasing order and other
compounds shown increasing in the a-helix (Supplementary data,
Table S2). This trend is similar to that obtained from FTIR studies
(Supplementary data).
Quenching and binding parameters KSV (Stern-Volmer quench-
ing constant), Kb (binding constant), Ka (association constant), n
(the number of ligand molecule per protein) and fa (the fractionof ﬂuorophore accessible to the quencher)} were calculated from
ﬂuorescence quenching data at 298 K with the help of Stern-
Volmer, modiﬁed Stern-Volmer and double-logarithm plots
[36,37]. The ﬂuorescence spectra of RNase A in the absence and
presence of rutin and quercetin and their copper complexes at
25 C are shown in Fig. 6(a)–(d), respectively. Interestingly, addi-
tion of quercetin and rutin and their copper complexes to RNase
A leads to a signiﬁcant quenching of the ﬂuorescence intensity of
tyrosine for all ligands despite differences observed in the mode
of inhibition in case of rutin. Quenching and binding parameters
for these ligands with RNase A are given in Table 2.
1H NMR Proton nuclear magnetic resonance (NMR) spectra of
RNase A are well characterized and the C(2)–H resonances of three
His residues out of four observed separately [38]. When a compet-
itive inhibitor binds to the enzyme, the chemical shifts (d) of the
C(2)–H of the active site His residues are expected to change. How-
ever, for a ligand not going to the active site, little or no change in
the d value of C(2)–H is expected [39]. As would be expected the
chemical shift will not be affected for non-competitive ligands. In
Fig. 7, the signals for the C(2) protons of His 12, His 105, His119
are indicated by a, b and c, respectively. No signiﬁcant chemical
shift of C(2)-H of His-12 or His-119 RNase A is observed after bind-
ing with rutin or quercetin (Fig. 7). For comparison, the d values of
His 12, 119 of 2/CMP, a known competitive inhibitor have been
shown where a signiﬁcant shift is observed when bound to RNase
A. For RNase A bound to RutCu and QuCu (Supplementary data) the
1H NMR spectra of RNase A does not show any change indicating
that neither the polyphenols or their copper complexes are in the
vicinity of the active site of the protein.
The effect of the polyphenols and their copper complexes on the
melting point of RNase A was determined and is shown as a ﬁrst
derivative in Fig. 8 for clarity. It is observed that rutin has a thermal
stabilization property showing a 2 C increase in the melting point
whereas the other ligands Qu, RutCu, QuCu show a decrease in the
melting point.
Fig. 5. CD spectra of (a) RNase A-Rut, (b) RNase A-Qu, (c) RNase A-RutCu, (d) RNase A-QuCu, (a) RNase A:ligand 1:1 (---), (b) RNase A:ligand 1:0.5 (. . .) and (c) Free
RNase A (—).
Fig. 6. Fluorescence quenching spectra of RNase A in absence (top) and presence of (a) Rut, (b) Qu, (c) RutCu and (d) QuCu in 20 mM phosphate buffer of pH 7.0; Ligand
concentrations: 0 to 15 lM.
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with RNase A is distinctly different than quercetin and the copper
complexes. Between the two copper complexes, QuCu is the morepotent inhibitor due to the presence of a greater stoichiometric
ratio of Cu(II) in the QuCu complex in comparison to RutCu. This
is reﬂected in the agarose gel studies and in the Ki values. All the
Table 2
The binding parameters for the interactions of quercetin, rutin and their copper
complexes with RNase A.
Systems Ksv (M1) Ka (M1) Kb (M1) n fa
Rut 6.41  104 4.90  104 4.85  104 1.10 1.12
Qu 5.10  104 3.27  104 3.73  104 1.13 1.76
RutCu 11.41  104 5.52  104 7.50  104 1.30 1.66
QuCu 7.20  104 3.42  104 4.86  104 1.15 1.58
Fig. 7. 1H NMR spectra of RNase A and its complexes with ligands the signal for C(2)
protons of His 12, His 105 and His119 indicated by a, b and c respectively.
Fig. 8. First derivative plots for melting point determination of RNase A in presence
of the ligands.
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the protein, the interaction pattern results in a situation that pro-
motes the ribonucleolytic activity of RNase A. It may be speculated
that the enzyme complex formed with rutin being more stable as
observed from the melting studies facilitates the binding of the
substrate resulting in a greater formation of the product. The ki-
netic parameters with b being non-zero only for rutin indicate that
both pathways to form the product are probable thus, increasing
the activity of the protein in the presence of rutin. With b = 0 for
quercetin and the copper complexes the possibility of this
particular route is ruled out. In these cases the formation of the
ESI complex is non-productive thus, leading to inhibition due to
depletion of available enzyme. Thus, regulation of enzymatic prop-
erties may be possible with the initiation of complexation with
metal ion. Based on the structural homology between RNase A
and angiogenin these complexes can be subsequently used forthe antiangiogenic therapy. Further studies are underway to ascer-
tain the effect of the complexes on the angiogenic activity of angio-
genin. Similar glycone ﬂavonoids may be further checked for their
ability to activate/inhibit the catalytic activity of RNase A and
angiogenin. Activation with enhancement of the ribonucleolytic
activity of the protein that is possible with rutin may prove bene-
ﬁcial for the degradation of RNA and may also assist in the wound
healing property of angiogenin since its angiogenic property is re-
lated to its catalytic potency [40–42].
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